LYRA Financials
Lyra Therapeutics Inc - Financial statements & key metrics
Stock Price
$0.20
Market Cap
$14.39M
P/E Ratio
-0.1
EPS
$-22.90
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$1.53M
Gross Profit
-
Operating Income
-
Net Income
$-93.44M
EPS (Diluted)
$-1.43
Balance Sheet Highlights
Total Assets
$66.35M
Total Liabilities
$54.75M
Shareholders Equity
-
Cash & Equivalents
$40.58M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-70.01M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-25032.0%
ROE
-404.5%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is LYRA revenue?
LYRA's most recent quarterly revenue was $1.53M. Annual revenue can be calculated by summing the four most recent quarters.
Is LYRA profitable?
LYRA reported a loss of $93.44M in the most recent quarter.
What is LYRA market cap?
LYRA has a market capitalization of $14.39M, making it a small-cap stock.
Does LYRA have debt?
View LYRA's balance sheet for debt information.
What is LYRA cash flow?
Cash flow data is available in the full financial statements.